Singapore markets closed

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.2100+0.1000 (+2.43%)
At close: 04:00PM EST
4.0800 -0.13 (-3.09%)
Pre-market: 04:20AM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts3233
Avg. Estimate-0.3-0.29-1.01-1.27
Low estimate-0.35-0.33-1.05-1.45
High estimate-0.24-0.25-0.95-1
Year ago EPS-0.35-0.28-1.57-1.01
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts3244
Avg. Estimate1.87M2.5M38.62M7.5M
Low estimateN/AN/A36.3MN/A
High estimate3.6M5M40M20M
Year ago sales2.82M553k10.65M38.62M
Sales growth (year/est)-33.70%352.10%262.60%-80.60%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.27-0.29-0.31-0.31
Actual EPS-0.35-0.28-0.15-0.28
Difference-0.080.010.160.03
Surprise %-29.60%3.40%51.60%9.70%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.3-0.29-1.01-1.27
7 days ago-0.3-0.29-1.01-1.27
30 days ago-0.38-0.3-1.11-1.56
60 days ago-0.45-0.38-1.22-1.86
90 days ago-0.45-0.38-1.22-1.86
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days3133
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLYELIndustrySector(s)S&P 500
Current qtr.14.30%N/AN/AN/A
Next qtr.-3.60%N/AN/AN/A
Current year35.70%N/AN/AN/A
Next year-25.70%N/AN/AN/A
Next 5 years (per annum)-7.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A